MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) ...
Boston Scientific has plans to acquire medtech company Nalu Medical, which specializes in developing and commercializing minimally invasive chronic pain solutions. Boston Scientific has been a Nalu ...
The US Food and Drug Administration (FDA) has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse pulsed field ablation (PFA) system. The approval marks a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results